After Viagra Fuss, Women's Groups Say 'Help Us, Too'


Women's groups are lobbying Congress to require coverage of female prescription contraceptives now that more and more insurance companies say they are willing to pay for at least a few doses per month of the male impotence pill Viagra.

According to one group, it's unfair for insurers to help men have more and better sex, while not helping women avoid unwanted pregnancies. "Viagra, in all seriousness, means more sex. And more sex means more need for effective contraception," says Gloria Feldt, president of the Planned Parenthood Federation.

Republican Sen. Olympia Snowe of Maine introduced a bill last year to require health insurers that pay for prescription drugs to cover contraceptive drugs, devices and services, but the bill went nowhere. And despite heavy pressure from women's groups, chances for passage of similar legislation this year are dicey at best. Democrat Harry Reid of Nevada, a Senate sponsor, says lack of interest in the issue "shows me what happens when you have a male-dominated legislature. If this were a problem that affected men, this thing would have passed decades ago."

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.